ALPRE Stock Chart & Stats
€3.20
€0.48(13.71%)
At close: 4:00 PM EST
€3.20
€0.48(13.71%)
Day’s Range― - ―
52-Week Range€0.90 - €4.00
Previous CloseN/A
Volume1.51K
Average Volume (3M)2.68K
Market Cap
€3.74M
Enterprise Value€14.91M
Total Cash (Recent Filing)€556.92K
Total Debt (Recent Filing)€5.52M
Price to Earnings (P/E)―
Beta0.34
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding3,952,233
10 Day Avg. Volume3,635
30 Day Avg. Volume2,677
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-1.64
Price to Sales (P/S)10.13
P/FCF Ratio-4.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.53
Revenue Forecast (FY)€1.58M
ALPRE FAQ
What was Predilife SA’s price range in the past 12 months?
Predilife SA lowest stock price was €0.90 and its highest was €4.00 in the past 12 months.
What is Predilife SA’s market cap?
Predilife SA’s market cap is €3.74M.
When is Predilife SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Predilife SA’s earnings last quarter?
Currently, no data Available
Is Predilife SA overvalued?
According to Wall Street analysts Predilife SA’s price is currently Overvalued.
Does Predilife SA pay dividends?
Predilife SA does not currently pay dividends.
What is Predilife SA’s EPS estimate?
Predilife SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Predilife SA have?
Predilife SA has 3,952,233 shares outstanding.
What happened to Predilife SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Predilife SA?
Currently, no hedge funds are holding shares in FR:ALPRE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Predilife SA
Founded in 2004 and headquartered in Villejuif, France, Predilife S.A. specializes in devising and commercializing sophisticated medical technologies and analytical models. The company's core offerings include preventative healthcare solutions and comprehensive breast screening tests. Among its notable products are MammoRisk, a diagnostic tool designed to forecast an individual's risk of developing breast cancer; DenSeeMammo, software for evaluating breast tissue density; and a specialized medical device developed for predicting prostate cancer risk.
Technical Analysis
Novacyt
―
Eurobio-Scientific SA
―
Eurofins-Cerep SA
―
Biosynex SA
―
ABL Diagnostics SA
―